Resources
Articles
Straight answers to the human factors questions medical-device teams ask most.
How are user needs defined and validated in the development of prefilled syringe drug delivery devices?
User needs for prefilled syringe drug delivery devices are defined by closely analysing how different users interact with the device, identifying challenges such as product identification, cap removal, and safe disposal. These needs are then validated through Human Factors evaluations that simulate real-use scenarios, ensuring the device is usable, safe, and effective across all intended user groups.
What does FDA guidance require for human factors in AI-enabled medical devices?
FDA guidance requires integrating human factors engineering throughout the lifecycle of AI-enabled devices. Submissions should detail user interface design, prioritise design-based risk mitigations over labelling, and conduct usability evaluations. Even without critical tasks requiring formal validation reports, manufacturers should follow human factors processes to demonstrate effective risk control.
What are the key changes in the latest FDA draft guidance on Use-Related Risk Analysis for drugs and combination products?
The FDA draft guidance on Use-Related Risk Analysis extends requirements to drug products with complicated dosing regimens, not just devices or combination products. It emphasises early human factors integration, iterative updates to risk analyses, and allows URRA documentation in regulatory submissions, possibly reducing the need for some human factors validation studies if adequate risk mitigation is shown.
How should sample sizes be determined for human factors studies in medical device development?
Sample sizes in human factors studies for medical devices should be selected based on study objectives, regulatory guidance, and device risk profile. Early formative evaluations may use 5 to 8 participants for rapid, iterative feedback, while summative evaluations typically require at least 15 per user group, as recommended by the FDA, to confirm safety and usability.
What is the role of human factors in FDA essential drug delivery outputs?
Human factors specialists help define essential drug delivery outputs by leveraging anthropometric data and conducting foundational capability studies. They also support output validation through simulated bench testing, literature reviews, and physical population assessments, ensuring device parameters such as activation or cap removal forces align with realistic user capabilities and regulatory requirements.
What are the main changes in FDA's 2026 medical device human factors guidances?
The updated guidances separate operational human factors processes from regulatory submission requirements. Key changes include introducing Decision Point D, which allows devices with critical tasks to avoid submitting validation test data if lifecycle evidence proves risk controls remain effective. Additionally, usability requirements and risk outputs must formally integrate into design inputs.
What does ISO 20417 require for lay-user medical device instructions for use?
ISO 20417 requires instructions for use for lay users to be written at a lower secondary education level, or an appropriate alternative specified in the use specification. However, readability scores alone do not ensure comprehension. Labelling is part of the user interface, requiring human factors methods to evaluate whether users can safely interpret and apply the information.